Match!

Improvement on metabolic syndrome in high fat diet-induced obese mice through modulation of gut microbiota by sangguayin decoction

Published on Jan 1, 2020in Journal of Ethnopharmacology3.414
· DOI :10.1016/j.jep.2019.112225
Junping Zheng1
Estimated H-index: 1
(Hubei University of Chinese Medicine),
Jing Zhang1
Estimated H-index: 1
(Hubei University of Chinese Medicine)
+ 6 AuthorsHongtao Liu1
Estimated H-index: 1
(Hubei University of Chinese Medicine)
Abstract
Abstract Ethnopharmacological relevance Our previous research found that Sangguayin (SGY) deccoction made by four dietary and medicinal plant components (Leaf of Morus alba L., Root of Pueraria lobata (Willd.) Ohwi., Root of Dioscorea opposita Thunb. and Fruit of Momordica charantia L.) showed significant anti-diabetic effects on db/db mice and high fat diet induced obese mice. Nevertheless, it remained unclear what the role of gut microbiota in the hypoglycaemia effects of SGY. Aims of the study This study aimed to examine the beneficial effects of Sangguayin Deccoction against metabolic syndrome and and its regulating role in gut microbiota and hepatic metabolome. Materials and methods C57BL/6J mice were divided to a normal chow diet (NCD), high-fat diet (HFD), and high-fat diet with Sangguayin Decoction (HFD-SGY, oral dose of 250 mg/kg/d) for 16 weeks. Next generation sequencing was applied for analyzing the gut microbial community of colonic contents. Further, untargeted metabolomic analysis based on LC-MS was used for determining the changes of hepatic metabolites. Hepatic genes expression were measured by quantitative PCR. Results SGY supplement decreased blood glucose level and glucose intolerance. Illumina MiSeq sequencing revealed that SGY increased Verrucomicrobia phylum, resulting in a bloom of Akkermansia, and eventually upregulated the contents of Lachoclostridium and Roseburia. Additionally, dietary SGY decreased bacteria including Faecalibaculum, and Blautia. Moreover, the hepatic lipid metabolism was notably altered by SGY treatment. The oxidation of glutamione metabolism idecreasees, production of poly-unsaturated fatty acid (PUFA) got significant increase in liver tissue. The reversion of PUFA metabolism by SGY may act through PPARα mediated Fads1 and Fads2 gene expression. The altered metabolites in liver showed intimate correlatship with modified genera. Conclusion Data indicated that SGY reshaped gut microbial structure and improved PUFA metabolism. These functions of SGY may alter hepatic lipid metabolism, conferring preventative effects against high-fat diet induced metabolic syndrome.
  • References (49)
  • Citations (2)
📖 Papers frequently viewed together
2019
3 Authors (Sheng Liu, ..., Jing Wang)
6 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References49
Newest
#1Tsung-Ru Wu (CGU: Chang Gung University)H-Index: 5
#2Chuan-Sheng LinH-Index: 12
Last. Hsin-Chih LaiH-Index: 30
view all 10 authors...
Objective The medicinal fungus Ophiocordyceps sinensis and its anamorph Hirsutella sinensis have a long history of use in traditional Chinese medicine for their immunomodulatory properties. Alterations of the gut microbiota have been described in obesity and type 2 diabetes. We examined the possibility that H. sinensis mycelium (HSM) and isolated fractions containing polysaccharides may prevent diet-induced obesity and type 2 diabetes by modulating the composition of the gut microbiota. Design H...
30 CitationsSource
#1Lulu Sun (PKU: Peking University)H-Index: 5
#2Cen Xie (NIH: National Institutes of Health)H-Index: 19
Last. Changtao Jiang (PKU: Peking University)H-Index: 25
view all 28 authors...
The anti-hyperglycemic effect of metformin is believed to be caused by its direct action on signaling processes in hepatocytes, leading to lower hepatic gluconeogenesis. Recently, metformin was reported to alter the gut microbiota community in humans, suggesting that the hyperglycemia-lowering action of the drug could be the result of modulating the population of gut microbiota. However, the critical microbial signaling metabolites and the host targets associated with the metabolic benefits of m...
59 CitationsSource
#1Shubha Ghosh Dastidar (University of Louisville)H-Index: 2
#2Ganapathy Jagatheesan (University of Louisville)H-Index: 5
Last. Daniel J. Conklin (University of Louisville)H-Index: 28
view all 7 authors...
Hepatic glutathione S-transferases (GSTs) are dysregulated in human obesity, nonalcoholic fatty liver disease, and diabetes. The multifunctional GST pi-isoform (GSTP) catalyzes the conjugation of g...
1 CitationsSource
#1Isabel Leiva-GeaH-Index: 1
#2Lidia Sánchez-Alcoholado (UMA: University of Málaga)H-Index: 8
Last. María Isabel Queipo-Ortuño (UMA: University of Málaga)H-Index: 29
view all 9 authors...
OBJECTIVE Type 1 diabetes is associated with compositional differences in gut microbiota. To date, no microbiome studies have been performed in maturity-onset diabetes of the young 2 (MODY2), a monogenic cause of diabetes. Gut microbiota of type 1 diabetes, MODY2, and healthy control subjects was compared. RESEARCH DESIGN AND METHODS This was a case-control study in 15 children with type 1 diabetes, 15 children with MODY2, and 13 healthy children. Metabolic control and potential factors modifyin...
12 CitationsSource
#1Alida Kindt (LEI: Leiden University)H-Index: 3
#2Gerhard LiebischH-Index: 46
Last. Josef Ecker (TUM: Technische Universität München)H-Index: 13
view all 19 authors...
Interactions between the gut microbial ecosystem and host lipid homeostasis are highly relevant to host physiology and metabolic diseases. We present a comprehensive multi-omics view of the effect of intestinal microbial colonization on hepatic lipid metabolism, integrating transcriptomic, proteomic, phosphoproteomic, and lipidomic analyses of liver and plasma samples from germfree and specific pathogen-free mice. Microbes induce monounsaturated fatty acid generation by stearoyl-CoA desaturase 1...
11 CitationsSource
#1Célia Bidu (French Institute of Health and Medical Research)H-Index: 2
#2Quentin Escoula (French Institute of Health and Medical Research)H-Index: 3
Last. Jérôme Bellenger (French Institute of Health and Medical Research)H-Index: 4
view all 13 authors...
Altering the gut microbiome may be beneficial to the host and recently arose as a promising strategy to manage obesity. Here, we investigated the relative contribution of ω3 polyunsaturated fatty acid (PUFA)–mediated alterations in the microbiota to metabolic parameter changes in mice. Four groups were compared: male fat-1 transgenic mice (with constitutive production of ω3 PUFAs) and male wild-type (WT) littermates fed an obesogenic (high fat/high sucrose [HFHS]) or a control diet. Unlike WT mi...
15 CitationsSource
#1Junping Zheng (CAS: Chinese Academy of Sciences)H-Index: 4
#2Xubing Yuan (CAS: Chinese Academy of Sciences)H-Index: 3
Last. Hongtao Liu (CAS: Chinese Academy of Sciences)H-Index: 19
view all 9 authors...
Abstract The aim of this study is to investigate the effect of chitosan oligosaccharides (COS) on type 2 diabetes mellitus. Wild type C57BL/6J mice or diabetic db/db mice were treated with vehicle or COS for three months. COS treatment significantly decreased the blood glucose ( P 0.01) and reversed the insulin resistance ( P 0.05) in db/db mice, which was accompanied by suppressing the inflammation mediators ( P 0.05), down-regulating the lipogenesis ( P 0.01) and inhibiting the adipocyte diffe...
19 CitationsSource
#1Xiaolin TongH-Index: 14
#2Jia Xu (SJTU: Shanghai Jiao Tong University)H-Index: 30
Last. Liping Zhao (SJTU: Shanghai Jiao Tong University)H-Index: 40
view all 24 authors...
27 CitationsSource
#1Abraham MeijnikmanH-Index: 1
#2Victor E. A. GerdesH-Index: 32
Last. Hilde HerremaH-Index: 8
view all 4 authors...
The pathophysiology of obesity and obesity-related diseases such as type 2 diabetes mellitus (T2DM) is complex and driven by many factors. One of the most recently identified factors in development of these metabolic pathologies is the gut microbiota. The introduction of affordable, high-throughput sequencing technologies has significantly expanded our understanding of the role of the gut microbiome in modulation of host metabolism and (cardio)metabolic disease development. Nevertheless, evidenc...
36 CitationsSource
#1Qi-Chang Xing (Hubei University of Chinese Medicine)H-Index: 2
#2Yun-Zhong Chen (Hubei University of Chinese Medicine)H-Index: 2
Sangguayin (SGY), comprising four types of Chinese herbs, can be used as both food and medicine and has been clinically used to treat type 2 diabetes mellitus (T2DM) for a long time. Our previous study demonstrated the antidiabetic effect of SGY in experimental T2DM rats fed with a high-fat diet and treated with a low dose of streptozotocin. However, its mechanism of action is questionable. In this study, we refined the traditional SGY decoction and investigated its antidiabetic activity in db/d...
3 CitationsSource
Cited By2
Newest
#1Zenghao YanH-Index: 2
#2Hao Wu (SYSU: Sun Yat-sen University)H-Index: 2
Last. Yonggang WangH-Index: 1
view all 8 authors...
Rotundic acid (RA) is a major triterpene constituent in the barks of Ilex rotunda Thunb, which have been widely used to make herbal tea for health care in southern China. RA has a variety of bioactivities such as anti-inflammation and lipid-lowering effect. However, little is known about the effects and mechanisms of RA on metabolic disturbance in type 2 diabetes (T2D) and its effect on gut microbiota. A T2D rat model induced by high fat diet (HFD) feeding and low-dose streptozotocin (STZ) injec...
Source
Osteoarthritis (OA) is considered a major cause of disability around the globe. This handicapping disease causes important cartilage and bone alteration that is associated with serious pains and loss of joint function. Despite its frequent association with obesity, the aetiology of OA is not fully understood. In this review, the different aspects of OA and its correlation with obesity were analysed. Through examining different mechanisms by which obesity may trigger and/or exacerbate OA, we poin...
Source